National Institutes of Health logo
Program

Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases

Funds short, exploratory clinical trials — from first-in-human through Phase II — for arthritis, musculoskeletal and skin disease treatments.

Between a promising idea and a full clinical program sits a short, exploratory trial that tells you whether the idea survives contact with a real patient. This notice funds that stage for NIAMS's diseases specifically.

The Exploratory Clinical Trials Grants Program supports research toward preventing or reducing symptoms and improving outcomes and function in patients with rheumatic, musculoskele

BiotechMedtech

Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.

Last verified: 27 Aug 2026Source: www.grants.gov